ZERO Cancer

Accomplishments

Federal Research Funding

Over the past 15 years, ZERO has increased the federal investment in prostate cancer research from $80 million to more than $450 million annually. Nearly every treatment breakthrough in prostate cancer in the last five years has been funded by, at least in part, federal funding secured by ZERO.

ZERO spearheaded the creation of the Congressionally Directed Medical Research Program for Prostate Cancer at the Department of Defense. The program funds $80 million in research each year. The program specializes in speeding new treatments from the science bench to the patient's bedside. Every dollar donated to ZERO is leveraged into $80 for research at the DOD.

Great Prostate Cancer Challenge & DASH FOR DAD

In 2008, ZERO started the race series by partnering with large group urology practices like Chesapeake Urology and Urology Associates of Nashville to build the premier men's health event series in America. In 2011, we will host 27 races with 15,000 participants.

Drive Against Prostate Cancer

More than 110,000 men have been tested for free onboard the Drive Against Prostate Cancer mobile medical program since 2002. From tracking high PSA test results and then alerting those men to see their doctor, the Drive has saved as many as 12,000 lives.

Summit to End Prostate Cancer

As the largest annual prostate cancer advocacy gathering in Washington, D.C., The Summit hosts more than 150 participants each year. In 2010, then-House Speaker Nancy Pelosi and U.S. Senators Kerry and Sessions attended the reception.

Powered by ARCOS | Design by Floyd & Partners

ZERO — The Project to End Prostate Cancer · 10 G St., NE · Suite 601 · Washington, DC 20002 · P: 202-463-9455 · F: 571-257-8559

BBB Accredited Charity Validate TRUSTe privacy certificationZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health service provider. If you have problems with the site or need more information, please call us at 1.888.245.9455 or e-mail your comments. All names, logos and articles are the copyrights of the respective owners.

© 2011 All Rights Reserved. Contact Us | Privacy Policy